4/A//SEC Filing
ANTHONY LAURA E 4/A
Accession 0001213900-20-031870
CIK 0001726711other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 8:37 PM ET
Size
5.6 KB
Accession
0001213900-20-031870
Insider Transaction Report
Form 4/AAmended
ANTHONY LAURA E
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-10-13+10,000→ 10,000 totalExercise: $1.94Exp: 2030-10-13→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]25% of the stock options vest immediately, and the remaining 75% of the stock options will vest in three equal quarterly installments on the last day of each subsequent fiscal quarter, beginning December 31, 2020.
Documents
Issuer
ADiTx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001174306
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 8:37 PM ET
- Size
- 5.6 KB